Sanofi ADR

Yahoo Finance • 10 hours ago

Why Apogee Slipped On Its Dupixent-Rivaling Eczema Results

Apogee Therapeutics revealed mixed results for its experimental eczema treatment Wednesday, and the stock dropped. Continue Reading... Full story

Yahoo Finance • 2 days ago

Recursion Pharmaceuticals Just Hit a 52-Week Low. Is This Former Nvidia Holding a Smart Buy Now?

Key Points Recursion Pharmaceuticals is using AI to improve how we develop drugs. The company has partnered with several major corporations in this quest. The biotech has yet to show meaningful results from its approach. 10 stocks we lik... Full story

Yahoo Finance • 7 days ago

Hepatitis A Market Research Report 2026-2036: Ecosystem, Marketed and Emerging Therapies, Epidemiological Analysis, Pipeline, Clinical Trial Landscape, Regulations Featuring GSK, Merck, and Sanofi

Company Logo The global Hepatitis A vaccine market is expanding due to increased disease awareness, government immunization initiatives, and rising international travel. Countries worldwide are implementing vaccination programs, bolsterin... Full story

Yahoo Finance • 7 days ago

Paroxysmal Supraventricular Tachycardia Market Analysis Report 2026-2036, Profiles of Leading Players - Medtronic, Boston Scientific, Abbott Laboratories, Milestone Pharmaceuticals, Sanofi, Pfizer

Company Logo The global Paroxysmal Supraventricular Tachycardia (PSVT) market is set for significant growth, driven by advancements in diagnostics and treatment, and rising cardiovascular awareness. Key factors include a surge in cardiova... Full story

Yahoo Finance • 7 days ago

Hemorrhoids Treatment Market Research Report 2026-2036: Epidemiological Analysis, Treatment and Management, Trends, Clinical Trial Landscape, Pipeline Analysis, Regulatory Landscape

Company Logo The global hemorrhoids market is poised for steady growth due to increased awareness, improved treatments, and rising prevalence from factors like aging, sedentary lifestyles, and poor diets. Common worldwide, hemorrhoids imp... Full story

Yahoo Finance • 10 days ago

Kernicterus Market Research and Forecast Report 2026-2036 Featuring Pfizer, F.Hoffmann La Roche,. Merck, AbbVie, AsteraZeneca, Abbott Laboratories, Sanofi, GlaxoSmithKline, Grifols

Company Logo The kernicterus market is experiencing growth, fueled by an increase in neonatal jaundice cases, particularly among preterm infants. Major drivers include advancements in neonatal screening protocols and the development of no... Full story

Yahoo Finance • 10 days ago

Regeneron Stock Sinks as Key Melanoma Drug Trial Fails to Beat Merck’s Keytruda

A late-stage trial evaluating Regeneron’s fianlimab, a skin cancer drug, fails to meet its primary endpoint. Continue Reading... Full story

Yahoo Finance • 11 days ago

The Top 5 Analyst Questions From Novavax’s Q1 Earnings Call

Novavax delivered first quarter results that surpassed Wall Street’s revenue and earnings estimates, leading to a significant positive market reaction. Management attributed the quarter’s performance to strong partner-driven revenue stream... Full story

Yahoo Finance • 13 days ago

FDA leadership fallout continues as acting CDER Director Hoeg expected to depart

[FDA headquarters in Washington DC.] JHVEPhoto * Just days after Marty Makary left [https://seekingalpha.com/news/4591441-fda-commissioner-makary-getting-fired-tuesday] as FDA commissioner on May 12, Tracey Beth Hoeg, the acting leader... Full story

Yahoo Finance • 16 days ago

Trinity's TGaS Advisors Announces Winners of 9th Annual Best of Benchmark Awards

Boehringer Ingelheim, Genentech, Gilead, GSK, Lilly, Neurelis, Novartis and Sanofi Recognized for Operational Excellence WALTHAM, Mass., May 12, 2026 /PRNewswire/ -- Trinity, a leader in strategy, insights and analytics for the life scien... Full story

Yahoo Finance • 19 days ago

Trump says unaware of a plan to fire FDA commissioner

Anna Moneymaker/Getty Images News Amid multiple reports suggesting that President Donald Trump has signed off on a plan to oust FDA commissioner Marty Makary, Trump said late Friday that he is completely unaware of such a proposal. The W... Full story

Yahoo Finance • 20 days ago

Is This Biotech Stock a Buy After a Groundbreaking Approval?

Key Points Regeneron earned approval for a gene therapy for hearing loss. The company's decision to offer it for free makes more sense than it seems at first. The biotech leader has a lot going its way right now.10 stocks we like better t... Full story

Yahoo Finance • 20 days ago

The Agencies Building Pharma's Next Decade Just Picked Their Software: Daily Command Launches With 18 of the Industry's Most Senior Agency Leaders Already Inside It

Sanofi, Merck, Bristol Myers Squibb, Eli Lilly, Avalere Health, Deerfield, Havas Media, Omnicom Health Group, Real Chemistry, EVERSANA, Klick Health, Ogilvy Health and others among the firms whose senior leaders co-built Doceree's Daily Co... Full story

Yahoo Finance • 20 days ago

75 of Pharma's Most Senior Marketers Just Walked Away From a $12 Billion Tool Stack

In a coordinated public declaration at the Doceree Makers Summit, brand and commercial leaders from Sanofi, Merck, Bristol Myers Squibb, Eli Lilly, Avalere Health, Deerfield, and others co-signed a new operating model for pharma marketing... Full story

Yahoo Finance • 21 days ago

Post-Marketing Pharmacovigilance and Medical Information Market Analysis Report 2026: $11.89 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, May 07, 2026 (GLOBE NEWSWIRE) -- The "Post-Marketing Pharmacovigilance and Medical Information Market Report 2026" has been added to ResearchAndMarkets.com's offering. The post-marketing pharmacovigilance and medical informatio... Full story

Yahoo Finance • 21 days ago

IgG4-Related Disease Market Analysis and Forecasts, 2025-2026 & 2035 with Amgen, Zenas BioPharma, Bristol Myers Squibb, and Sanofi Leading

Company Logo Global IgG4-related disease market sees growth due to increased research funding and development of targeted therapies. This rare autoimmune condition results in inflammation and organ dysfunction. Emerging biologic treatment... Full story

Yahoo Finance • 21 days ago

Vicore Pharma Elects Peter Guenter to its Board of Directors

Appointment strengthens Vicore's board with nearly four decades of global pharmaceutical leadership as the company advances buloxibutid toward an important late-stage data readout STOCKHOLM, SE / ACCESS Newswire / May 7, 2026 / Vicore Pha... Full story

Yahoo Finance • 22 days ago

This Small Biotech — Taking On AbbVie, Novartis And Sanofi — Just Catapulted Into A Breakout

Biotech stock Avalo Therapeutics skyrocketed to a two-year high Wednesday on positive results for its skin disease treatment. Continue Reading... Full story

Yahoo Finance • 23 days ago

Zifo's SiEE Boston Summit Charts New Roadmap for 'Practical AI' in Life Sciences, Bridging the Gap Between Business Vision and Lab Reality

BOSTON, May 5, 2026 /PRNewswire/ -- Trading the abstract allure of AI hype for a technical implementation roadmap, Zifo's 2026 Scientific Informatics Experience Exchange (SiEE) in Boston concluded with heavyweights from Sanofi, Takeda, Abb... Full story

Yahoo Finance • 23 days ago

Dupixent® (dupilumab) Demonstrates Improved Esophageal Function in Eosinophilic Esophagitis (EoE) Phase 4 Trial

Regeneron Pharmaceuticals, Inc. Dupixent showed significant and clinically meaningful improvements in both esophageal distensibility as well as disease-related structural changes and inflammation in the esophagus in adult patients with Eo... Full story